Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced two presentations at the upcoming...
Morgan Stanley analyst Terence Flynn maintains United Therapeutics (NASDAQ:UTHR) with a Equal-Weight and raises the price ta...
UBS analyst Ashwani Verma maintains United Therapeutics (NASDAQ: UTHR) with a Buy and raises the price target from $560 to $...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...
RBC Capital analyst Lisa Walter initiates coverage on United Therapeutics (NASDAQ: UTHR) with a Outperform rating and announ...
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that recent research across its c...
Cantor Fitzgerald analyst Olivia Brayer maintains United Therapeutics (NASDAQ:UTHR) with a Overweight and raises the price t...
These ten large-cap stocks were top performers last week. Are they a part of your portfolio?
